Royalty Rates for Pharmaceuticals & Biotechnology features more real-deal royalty rates, license fees, and milestone payment benchmarks than any other publication. The ninth edition of Royalty Rates for Pharmaceuticals & Biotechnology contains hundreds of royalty rates and other financial compensation benchmarks that can be used to optimize the pricing of biotechnology and pharmaceutical innovations. You'll find updated and expanded information from past editions as well as an increased number of reported license agreements. This new edition and the transaction details have been collected from well-established sources over a period of 22 years of research. Royalty Rates for Pharmaceuticals & Biotechnology provides real-deal information for hundreds of transactions, including the technology licensed, royalty rates, license fees, and milestone payments. And it goes well beyond the rates to provide context for each deal analyzed. This unique resource is organized into two useful sections: The first section covers the theory associated with deriving royalty rates. An overview of intellectual property value is included along with seven methods that can be employed to derive royalty rates: Simple Rules of Thumb, Industry Guidelines, Discounted Cash Flow Analysis, Risk-Adjusted Net Present Value Analysis, Infringement Damages Analysis, Comparable License Transactions, Investment Rate of Return Analysis, and the Relief-From-Royalty Method. The second section of this one-of-a-kind report presents detailed financial information from real-world transactions. You'll find information on the parties involved in the transactions along with a description of the technology exchanged and all financial details that could be discovered. This publication is designed to provide accurate and authoritative information about the subject matter covered. All of the information in this report has been obtained from reputable and reliable sources and is therefore believed to be accurate. The publisher accepts no responsibility for any damages that any party may experience from relying on the information presented herein.
Table of Contents
- 1,2-diphenylethanes, 1,3-diphenylpropanes and benzyl tetralins
- Abuse Deterrent
- Actimmune - interferon gamma-1b
- Adult Growth Hormone Deficiency
- Agriculture - Animal Health/Trilostane
- Agriculture - Golden Rice
- Alcohol Dependency Treatment
- Aldurazyme - recombinant form of the human enzyme alpha-L-iduronidase
- Alpha Interferon - Natural
- Alzheimer’s Treatment
- Alzheimer's Diagnostic Test
- Anemia
- Anesthetic
- Animal Health Products
- Antibiotic - Brilacidin
- Antibiotic - Monoclonal
- Antibiotic - VIBATIV®
- Antibodies - Primatized
- Antibodies - Primatized Anti-CD4
- Antifungal
- Antifungal Agent - Amphotericin B
- Anti-hypertension Therapy
- Anti-infection Screening Process
- Anti-inflammatory - Topical
- Anti-inflammatory Drug BB-882
- Anti-retroviral medicine - Viread
- Anti-viral - COVID-19
- Anti-viral - COVID-19 Treatment
- Anti-viral - COVID-19 Vaccine
- Antiviral and Anti-infective Therapies
- Anti-viral and Anti-infective Therapies
- Anti-viral Barrier
- Anti-viral Therapy
- Arginine Products
- Arthritis - Rheumatoid - Drug Humira
- Asthma Drug - Oral Administration
- Attention Deficit Hyperactivity Disorder
- Attention Deficit Hyperactivity Disorder Therapy
- Autoimmune Disease Therapy
- Automated Cell Processing Instrument
- Automated Process Research
- Bacterial Infections
- BetaKine (TGF-beta-2)
- Bicifadine
- Biochemical Technology Portfolio
- Blood - Hematology Controls Using Reticuulotytes
- Blood - Hemophilia B
- Blood Cell and Bone Marrow Production
- Blood Cell Therapy
- Blood Clot Formation Test
- Blood Clot Treatment
- Blood Expander
- Blood Plasma Volume Expander
- BPI - Human Protein
- Cancer
- Cancer - ADCETRIS
- Cancer - Aflibercept
- Cancer - Alfa Interferone
- Cancer - ALTR1550
- Cancer - AMD473
- Cancer - Anticancer ImmunityTreatment
- Cancer - Brain
- Cancer - Ceeplen® Leukemia Treatment
- Cancer - Hedgehog Pathway Inhibitor
- Cancer - Rhabdomyosarcoma
- Cancer - Tarceva
- Cancer - TGF
- Cancer - Treatment
- Cancer - Tumore Treatment
- Cancer - Tyrosine Kinase Inhibitor
- Cancer Diagnostics
- Cancer- Histone Deacetylase (HDAC) Inhibitors
- Cancer LukemiaTreatment
- Cancer Research Technology
- Cancer Therapy
- Cancer Therapy - AKT-mTOR Pathway
- Cancer Therapy - Delivery
- Cancer Therapy - Diagnostics
- Cancer Therapy - Lymphoma
- Cancer Therapy - Lymphomam B Cell Non-Hodgkin’s
- Cancer Therapy - Metastic Melanoma
- Cancer Therapy - Monoclonal Antibody
- Cancer Therapy - Mouse
- Cancer Therapy - Multiple Melanoma, Relapsed
- Cancer Therapy - Myelodysplastic Syndrome
- Cancer Therapy - Myelomonocytic Leukemia
- Cancer Therapy - NeoRx's Avicidin®
- Cancer Therapy - Oral Mucositis Treatment
- Cancer Therapy - Ovarian Cancer
- Cancer Therapy - Pancreatic
- Cancer Therapy - Phenoxodiol
- Cancer Therapy - Prolanta™ Manufacturing Process
- Cancer Therapy - Radiation Drug
- Cancer Treatment
- Cancer Treatment - 9-Aminocamptothecin
- Cancer Treatment - Antisense Oligonucleotides
- Cancer Treatment - Basal Cell Carcinoma Nevus Syndrome
- Cancer Treatment - B-CLL
- Cancer Treatment - Bladder
- Cancer Treatment - Blood Cells
- Cancer Treatment - Brain Malignancy
- Cancer Treatment - Carbohydrate Compounds
- Cancer Treatment - Cervical Cancer
- Cancer Treatment - Clofarabine
- Cancer Treatment - Colorectal and Pancreatic
- Cancer Treatment - Colorectal Cancer
- Cancer Treatment - CRx-026
- Cancer Treatment - DBD/Mitolactol
- Cancer Treatment - Disodium Clodronate
- Cancer Treatment - Doxorubicin Resistant Tumors
- Cancer Treatment - Electrostatic Lipsome
- Cancer Treatment - Endometrial
- Cancer Treatment - Epidermal Growth Factor
- Cancer Treatment - Foscan
- Cancer Treatment - Gliadel
- Cancer Treatment - huN901-DM1 Tumor-Activated Prodrug (TAP)
- Cancer Treatment - IFN-Gamma Susceptible Diseases
- Cancer Treatment - Immunosuppressive Microenvironment
- Cancer Treatment - Kaposi’s Sarcoma
- Cancer Treatment - Keytruda
- Cancer Treatment - Lung Cancer
- Cancer Treatment - Lymphoblastic Leukemia
- Cancer Treatment - Lymphocytic Leukemia
- Cancer Treatment - Maytansinoid Tumor-Activated Prodrug (TAP)
- Cancer Treatment - Nexavar™
- Cancer Treatment - Non-small Cell Lung
- Cancer Treatment - Oncolysin B
- Cancer Treatment - Optisomes
- Cancer Treatment - Oxygen Enhancement
- Cancer Treatment - Prostate
- Cancer Treatment - Radio Labeled Antibody
- Cancer Treatment - Ribonucleases
- Cancer Treatment - Urinary Tract
- Cancer Treatment - Vaccines
- Cancer Treatment OSI-774
- Cancer Tumor Treatment
- Cannabinoid Receptor Meditating Compounds
- Cardiorenal Disease Therapies
- Cardiovascular
- Cardiovascular - Adenocard
- Cardiovascular - Angina
- Cardiovascular - Arrhythmias
- Cardiovascular - Atherosclerosis
- Cardiovascular - Beta Blocker
- Cardiovascular - Bextra™
- Cardiovascular - Blood Pressure and Cholesterol
- Cardiovascular - Blood Thinner
- Cardiovascular - Cell Transplant Treatment
- Cardiovascular - Cholesterol
- Cardiovascular - Elafin™
- Cardiovascular - Endothelial Dysfunction
- Cardiovascular - Heart Cell Growth
- Cardiovascular - Hypertension
- Cardiovascular - Hypertrophy
- Cardiovascular - Risk Reduction
- Cardiovascular - Synthetic Heart Graft Drug
- Cardiovascular - Thrombosis Therapy
- Cardiovascular Generic Drug - ThromboClear
- Cardiovascular Nebulizer
- Cartilage Regenerative Technology
- Catheter Technology
- cdkl Assay
- Cell Adhesion Technology - LEC-CAM
- Cell Cultures
- Chimeric IgG1 antibodies
- Cholesterol High LDL Treatment
- Cholesterol Treatment
- Chromosome Analysis Technology
- Chronic Obstructive Pulmonary Disease Therapy
- Cochleates, Liposomes and Proteoliposomes
- Cold Remedy
- Collagenase Ointment
- Consensus Interferon
- Contraceptive
- Contrast Agent - Intravenous
- COPD Treatment
- Coronary Drug-eluting Stent
- Cough Medicine
- Crohn’s Disease Therapy
- Cyclin Dependent Kinasc Assay Test Kit
- Cypress Stem Cells
- Cystic Fibrosis Treatment
- Cytomegalovirus Intravenous Treatment
- Deferrum® deferiprone
- Dermatology
- Diabetes
- Diabetes - CIPD Treatment
- Diabetes - Diabetic Peripheral Neuropathy
- Diabetes - Glumetza
- Diabetes - Juvenile
- Diabetes - PARL gene
- Diabetes - Pulmonary Administration of Insulin
- Diabetes - Type II
- Diabetes (Type II) Mellitus Drug
- Diabetic Macular Edema
- Diagnostic Alliance
- Diagnostic Imagining Using Ligands
- Dietary Supplement - Botanical
- Diltiazem Heart Drug
- DNA - PK
- DNA Binding Invention
- DNA Nanocircles
- DNA Synthesis
- Drug Delivery
- Drug Delivery - Controlled Release
- Drug Delivery - Topical
- Drug Delivery - Viral Infections
- Drug Delivery System - Pulmonary
- Drug Development Technology
- Drug Development, Botanical-based
- EGF Fusion Protein
- Eli Lilly & Co. Experiences Compulsory License Royalty Rates
- Enoxaparin
- Environmental Test Kit
- Enzyme Inhibitors
- Epilepsy Treatment - ADCI
- EPO, Hepatitis B and IL-2
- Erectial Dsyfuction Therapy - Vitaros™
- Erythronmycin Antibiotic
- Estrogen Replacement Therapy
- Fertility Treatment
- Fibrotic Disease Therapy - Pirfenidone
- Financing Research
- Fusion Inihibitors for HIV
- Gastrointestinal Infection
- Gastroretentive Drug Delivery Devices for Oral Intake
- Gene Activation Technology
- Gene Alteration Technology
- Gene Sequencing
- Gene Splicing Technology
- Gene Therapy Partnership Network
- Genetic Abnormalities Test - Prenatal
- Genetic Research
- Genetic Technology
- Genetically Engineered Listeria Immune Therapy
- Genomics-based Drug Discovery
- Glycogen Storage Disease III
- Hepatitis
- Hepatitis A Vaccine
- Hepatitis B
- Hepatitis B & C
- Hepatitis B and C Genetic Therapy
- Hepatitis C
- Hepatitis C - Telaprev
- Hepatitis E Vaccine
- Hereditary Angioedema
- Hereditary ATTR (hATTR) amyloidosis.
- HIV and AIDS - Protease Inhibitor Therapy
- HIV and Hepatitis Vaccines
- HIV Diagnosis and Treatment
- HIV Drugs
- HIV Treatment - (NNRTI)
- HIV Treatment - alpha interferon
- HIV Treatment - Interferon-g
- HIV Vaccine
- HIV Virl-entry Inhibitor
- Human Gene Technology
- Human Growth Hormone
- Human Monoclonal Antibodies Discovery Technology
- Human Monoclonal Antibodu - Adalimumab
- Humanization Antibody
- Humanized Antibody
- Humanized Monoclonal Antibody
- Hypertension Treatment- autologous gene therapy
- Hypertension Treatment- tadalafil
- Immune (idiopathic) Thrombocytopenic Purpura Therapy
- Immune System Enhancement
- Immune System Regulators - Cytokines
- Immunodeficiency
- Immunotoxin - MDX-RA
- Indiplon
- Infections - Bacterial
- Infertility Treatment - Male
- Inflammation Antibody-based Therapeutics
- Inflammatory - Topical Therapy
- Inflammatory Diseases
- Influenza Drug
- Inhaler Technology
- Insomnia
- Insomnia Therapy
- Integrelin Drug
- Interferon Gamma-1b
- Intracellular Receptor Technology
- Kidney Disease Treatment
- Liver Disease Therapy
- Living Cells Connective Tissue
- Lubrin®
- Lung Problems (Emphysema) Treatment
- Lupis Nephritis
- Lupus Nephritis
- Macular Degeneration Therapy
- Macular Therapy - Spinal Muscular Atrophy
- Mammary Cell Growth Inhibitor
- Metabolic Treatment
- Michellamine B/Tropical Vine Leaves
- Microorganism Detection in Water
- Microsponge Delivery System
- Migraine Relief
- Modulation of Opioid Receptors
- Monoclonal Antibodies Binding to TGF-B
- Monoclonal Antibodies to Gram Negative Sepsis-Related Bacteria
- Monoclonal Antibody 45-J Test
- Monoclonal Antibody Technology
- mRNA Technology
- Multiple Sclerosis
- Multiple Sclerosis - Relasping
- Multiple Sclerosis Therapy - Copaxone
- Naked DNA Technology
- Nanocrystalline Particles
- NASA Technology
- Nasal Decongestant
- Nasal Vitamin B-12 Therapy
- Natural Cell Signaling Phenomenon
- Nerve Repair
- Nervous System Therapeutics
- NeuroCell Joint Venture
- Neurodegenerative and Psychiatric Diseases Therapy
- Neurological
- Neurological - Dravet Syndrone
- Neurological - DYRK1A syndrome
- Neurological Depression Therapeutics
- Neurological Disorders
- Neurological Peptide Therapy
- Neurological Therapeutics
- Neurology - Menkes disease
- Neurotrophic Factor Commercialization
- Nicotine Addiction Treatment
- Nifedipine Crystals
- Novasome Lipid Vesicles Encapsulation Technology
- Nuclear Matrix Protein Technology
- Nucleic Acid Probe Technology
- Nucleic Acid Sequences for Detection
- Nucleic Acid Targeting
- Nucleic Acid Technologies
- Nureologogical Disorders Anti-agitation Drug
- Nutrition - Salt Alternative
- Obesity
- Obesity Therapy
- Opthalmic
- Opthalmic - Allergic Conjunctivitis
- Opthalmic - Dry Eye
- Opthalmic - Patent Formulation for Loteprednol Etabonate
- Oral Contraceptive
- Osteoarthritis Treatment for Animals
- Osteoporosis Compound 1-apiha-hydroxyvitamin D2
- Oxygenation
- Pain Management
- Pain Management - Abuse Resistant
- Parkinson’s Disease
- PEG Enhanced L-asparaginase
- Pegylated Reagent
- Personal Care - Bioadhesive Delivery System
- Personal Care - Cosmetic Liposomal Formulations
- Personal Care - Facial Hair Treatment
- Personal Care - Hand Cleanser
- Personal Care - Kinetin™ Skin-Care Treatment
- Personal Care - Melanin Sunscreen Agent
- Personal Care - Moisturizers
- Personal Care - Mycrobicide Lotion
- Personal Care - Oral Treatment
- Personal Care - Serine Elastase Inhibitor Compound
- Personal Care - Skin Barrier Repair
- Personal Care - Skin Care Moisturizers
- Personal Care - Topical Antiseptics
- Personal Care - Various Products
- Pet Medication - Animal Feed
- Pet Medication - Bone Health
- Pet Medication - Crofelemer
- Pet Medication - Equidone
- Pet Medication - GI Field Technology
- Pet Medication - Immunobiotic
- Pet Medication - Interferon-g ("IFN-g")
- Pet Medication - NK-92
- Pet Medication - Trilostane
- Photodynamic Therapy
- Platinate HPMA Copolymer
- Pneumocystis Carinii Pneumonia
- Poly (ADP Ribose) Polymerase Diagnostic Assay
- Polymerase Chain Reaction Technology
- Pre-eclampsia/Toxemia Diagnosis and Therapy
- Primary Biliary Cholangitis
- Pro-Apolipoprotein A-I and Lipid Complexes
- Progesterone Gel
- Protein Secretion Technology
- Proteomics Technology
- Psychiatric & Psychotic Therapy
- Psychotherapeutic Drugs
- Pulmonary Disease
- Radynilel Hypoxic Tumor Cell Radiosensitizer
- Rapid Diagnostic Test
- RAS Human Protein/Rational Drug Design
- Recombinant Human Erythropoietin- Procrit®
- Recombinant Human Inerlukin-twelve (rhIL-1 2)
- Recombinant Technology
- Respiratory Therapy
- Retinoids
- Rhenium Radiotherapy and Monoclonal Antibodies
- Ribozymes
- Rickets - x-linked hypophosphatemia treatment
- RNAi Interference Technology
- RNAi Interference Therapies
- Sarafem®
- Schizophrenia
- Schizophrenia and Bipolar Treatment
- Septic Shock Treatment - Human Thymosin beta 4 (Tß4), a 43-amino acid peptide
- Sexual Dysfunction Therapy
- Skin Disorder
- Skin Technology - Polyactive Polymer Biomaterial
- Sleep Therapy
- Sleep Therapy - Nasal Administration
- Spirulina
- Spleen Tyrosine Kinase (Syk) Inhibitor
- Stem Cell Proliferation Factor
- Stem Cell Technology and Materials
- Stem Cells
- Stem Cells - Pluripotent Novel Strains
- Stem-loop Vector Technology
- Stromal Derived Factor 1 (SDF-1) Peptide Agonists and Antagonists
- Sugar Substitute
- Tamiflu™
- Telavancin™ - Antibotic
- Testosterone Replacement
- TGF-beta
- Thalidomide
- Thalidomide Analogs
- Thymidine Kinase Isoenzyme Diagnostics
- Tissue Malignancy Treatments
- Topical Adminstration Technology
- Transdermal Estrogen Patch
- Tropical Plants
- Ultrasound Contrast Agent
- Vaccine Research
- Vaccines, gene-based
- Virus Prevention and Treatment - Coronavirus
- Virus Vaccines
- Wart Removal Products
- Water-Jel Sterile Burn Dressings
- Yeast-based Screening Technology
